Cs. Wilson et al., Cross-recognition of two middle T protein epitopes by immunodominant polyoma virus-specific CTL, J IMMUNOL, 162(7), 1999, pp. 3933-3941
We recently identified the immunodominant epitope for polyoma virus-specifi
c CTL as the D-k-associated peptide MT389-397 derived from the middle T (MT
) viral oncoprotein, Another D-k-restricted peptide corresponding to residu
es 236-244 of MT was recognized by nearly all MT389-397-reactive CTL clones
, but required concentrations at least 2 logs higher to sensitize syngeneic
target cells for lysis, Except for identity at the three putative D-k-pept
ide anchor residues, MT236-244 shares no homology with MT389-397.Using a no
vel europium-based class I MHC-peptide binding immunoassay, we determined t
hat MT236-244 bound D-k 2-3 logs less well than MT389-397. Infection with a
mutant polyoma virus whose MT is truncated just before the MT389-397 epito
pe or immunization with MT389-397 or MT236-244 peptides elicited CTL that r
ecognized both MT389-397 and MT236-244. Importantly, infection with a polyo
ma virus lacking MT389-397 and mutated in an MT236-244 D-k anchor position
induced polyoma virus specific CTL recognizing neither MT389-397 nor MT236-
244 epitopes. Despite predominant usage of the V beta 6 gene segment, MT389
-397/MT236-244 cross-reactive CTL clones possess diverse complementarity-de
termining region 3 beta domains; this is functionally reflected in their he
terogeneous recognition patterns of alanine-monosubstituted MT389-397 pepti
des. Using D-k/MT389-397 tetramers, we directly visualized MT236-244 peptid
e-induced TCR down-modulation of virtually all MT389-397-specific CD8(+) T
cells freshly explanted from polyoma-infected mice, suggesting that a singl
e TCR recognizes both Dk-restricted epitopes, The availability of immunodom
inant epitope-specific CTL capable of recognizing a second epitope in MT, a
viral protein essential for tumorigenesis, may serve to amplify the CTL re
sponse to the immunodominant epitope and prevent the emergence of immunodom
inant epitope-loss viruses and virus-induced tumors.